Mark L. Rosenblum, MD,FAANS
Mark L. Rosenblum, MF, FAANS, is the chair emeritus of the Department of Neurosurgery in the Henry Ford Health System (HFHS) where he developed a department of 32 physicians and scientists that was nationally recognized for research and clinical excellence by US News and World Reports(14/15 years). There, he founded and served as co-director of the nationally recognized Hermelin Brain Tumor Center (National Cancer Institute(NCI), 21 years) and the HFHS Neuroscience Institute (SG2 and NeuroSource, 18 years). He also was one of 4 leaders that developed a new patient-focused Henry Ford West Bloomfield Hospital where he served as vice president of Clinical Programs and director of its Center for Health Services Transformation.
Outcomes for patients with malignant brain tumors are divided into either clinical outcomes (COs) or patient-reported outcomes (PROs). Clinical outcomes are measured by the physicians or their staff and define physical, anatomic or performance attributes. Patient-reported outcomes address the functional and psychosocial results of care and Quality of Life (QoL) through the patients’ eyes. Over the past 40 years,...
